CKD Awareness, Referrals, Education, and Support for Early-Stage CKD in Adults with Diabetes
Official title: CKD Awareness, Referrals, Education, and Support Intervention for Early-Stage CKD
Run by University of Illinois Chicago · NCT07210710 · Data updated 2026-11-12
This intervention tests whether education, motivational support, and social backing delivered virtually can help adults with diabetes and early CKD slow kidney decline and stay engaged with care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | University of Illinois Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | November 15, 2025 |
| Main results expected | December 30, 2026 |
| Study ends | July 31, 2027 |
| Registry record updated | October 9, 2026 |
| Trial ID | NCT07210710 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 and older with diabetes and eligible for CKD stage 3, who have had at least one prior UIHealth primary care visit and can speak English.
✕Probably not a fit
Patients who do not engage with virtual sessions or who have more advanced CKD or comorbidities not addressed by the program may see no benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a pilot interventional study evaluating a nurse-led, virtual education and support program called CARES for adults with diabetes and early-stage CKD. Participants receive a 1:1 virtual session about a week before a primary care visit and complete surveys by phone three times over three months. The study compares CARES to a control group receiving general diabetes information to see if the program improves motivation, self-efficacy, knowledge about CKD, and use of support services. Outcomes include feasibility, acceptability, and changes in patient-reported measures as well as potential effects on CKD-related care engagement. Enrollment targets adults 18+ with diabetes and CKD stage 3 who have had at least one prior visit at UIHealth primary care clinics and can speak English.
Why it matters
Potential benefit: If successful, CARES could help patients better manage CKD and stay connected to care, potentially slowing progression.
How similar studies have gone: Prior similar education and support interventions in CKD have shown potential to improve knowledge and engagement, but this exact virtual, nurse-led CARES approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * adults (18+) * diabetes diagnosis (type 1 or 2) * CKD Stage 3 diagnosis eligible * \>1 prior visit at the UIHealth primary care clinics * can speak English Exclusion Criteria: * CKD of congenital or pediatric onset * history of kidney transplant * cognitive impairment as documented in the medical record
Where it's running
-
University of Illinois Chicago Hospital
Chicago, Illinois, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Weight-loss with exercise and diet in adults with type 2 diabetes and CKD
This study tests whether a 12-week supervised aerobic exercise program plus a calorie‑restricted diet can change inflammatory and oxidative stress biomarkers in overweight adults with type 2 diabetes and moderate chronic kidney disease.
-
Examining how metabolism relates to body composition and size
This study is testing how metabolism connects to body size and composition in both healthy people and those with metabolic disorders to see if more accurate measurements can improve our understanding.
-
Health checks for diabetes, blood pressure, and kidney health in Indigenous communities.
This study is testing health checks for diabetes, blood pressure, and kidney health in Indigenous communities to see if it can help identify people at risk for kidney disease and improve their care.
-
Observational look at how Kremezin works in adults with advanced chronic kidney disease
This study tests whether Kremezin helps adults with advanced kidney disease when used as part of routine care, by tracking safety and kidney function over up to 48 weeks.
-
Kidney and Heart Health in Adults with Type 2 Diabetes and CKD Treated with Semaglutide in China
This study tests whether semaglutide injections help kidney and heart health in adults with type 2 diabetes and chronic kidney disease.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.